- Filed
- May 1, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 25, 2025 | 492.94M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $567M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $875M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $33M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $33M |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $12M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $12M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $1.98B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $2.23B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $3.41B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $3.59B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $5.07B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $5.56B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $7.55B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $7.5B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $19.97B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $19.97B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 498M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $133M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $151M |
| Capex | Q1 2025 · Mar 31, 2024 | $79M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $95M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $13.49B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $13.23B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $1.10 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $1.10 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $765M |
| Net Income | Q1 2025 · Mar 31, 2024 | $546M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $695M |
| Revenue | Q1 2025 · Mar 31, 2024 | $4.76B |